8-K - Pacific Biosciences of California, Inc. | StockGist

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

(c)(2) of Form 8-K regarding Mr. Gibson is included in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 23, 2025, and is

Management Change

7.01

. REGULATION FD DISCLOSURE. On March 5, 2026, the Company entered into a binding term sheet (the "Term Sheet") with Personal Genomics of Taiwan, Inc. (“PGI”) pu

Regulation Fd

Exhibits (1)

8-K